Egnyte Stock

egnyte.comEnterprise Software / Communication & Collaboration softwareFounded: 2007Funding to Date: $137.92MM

Egnyte’s all-in-one platform makes it simple and easy for IT to manage and control a full spectrum of content risks – from accidental data deletion, to data exfiltration, to privacy compliance and much more – all while giving business users the tools they need to work faster and smarter, from any cloud, any device, anywhere. This company was founded by Amrit Jassal, Kris Lahiri, Rajesh Ram, and Vineet Jain in 2007 and is headquartered in Mountain View, CA.

Register To Buy and Sell Shares

For more details on financing and valuation for Egnyte, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Egnyte’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Egnyte.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Vineet Jain
Co-Founder, Chief Executive Officer, President & Board Member
Ravi Chopra
Chief Financial Officer
Rajesh Ram
Co-Founder & Chief Strategy Officer
Amrit Jassal
Co-Founder & Chief Technology Officer
Julie Giannini
Chief Customer Officer
Frank Sicilia
Chief Information Officer
David Spitz
Chief Marketing Officer
Stan Hansen
Chief Revenue Officer
Ramin Farassat
Chief Strategy & Product Officer

Board Members

David Barrett
Polaris Partners
Holger Staude
Goldman Sachs Growth Equity
Karim Faris
GV
Matthew Murphy
Kleiner Perkins
Michael Maples Jr.
Floodgate Fund

Frequently Asked Questions About Egnyte’s Stock

plusminus
Can you buy Egnyte stock?
Egnyte is not publicly traded on NYSE or NASDAQ in the U.S. To buy Egnyte stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Egnyte stock?
Yes, you can sell stock of a private company like Egnyte. Forge can help you sell your Egnyte stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Egnyte’s stock price?
Egnyte is a privately held company and therefore does not have a public stock price. However, you may access Egnyte’s private market stock price with Forge Data.
plusminus
What is Egnyte’s stock ticker symbol?
Egnyte does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

As Egnyte continues to grow steadily, an IPO seems like the inevitable conclusion
Egnyte has never been a startup in a hurry and has been content to take a slow but steady growth trajectory over its 15-year history. Today it’s a $200 million company growing at around 25% a year. That’s pretty impressive for a private company at a time when many enterprise SaaS companies are struggling to reach double digits.
Egnyte Helps Teams Improve Productivity with Enhanced Functionality Across Product Lines
Egnyte, the secure platform for content collaboration and governance, announced several product enhancements across security and governance, mobile, and the Egnyte for Life Sciences’ Controlled Document Management application. These updates improve the functionality of the Egnyte platform so that customers can work faster and smarter.
Vial Partners With Egnyte to Integrate Life Sciences eTMF Solution into Clinical Trial Platform
Vial, a technology-first CRO, has announced a partnership with Egnyte, a leader in cloud content security and governance, to integrate its Life Sciences eTMF (electronic trial master file) solution into Vial’s platform. Egnyte eTMF is a 21 CFR Part 11 compliant platform that reduces document processing time, maintains compliance, and increases audit readiness for life sciences companies.
Updated on: Dec 8, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.